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Four different P-lactamases have been found in several strains of Xanthomonas maltophilia isolated from
blood cultures during 1984 to 1991 at the Edinburgh Royal Infirmary. One was a metallo-o-lactamase with
predominantly penicillinase activity and an isoelectric point of 6.8. Its molecular size as determined by gel
filtration was 96 kDa but was only 26 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), suggesting a tetramer of four equal subunits. The enzyme hydrolyzed all classes of P-lactams
except the monobactam aztreonam. This enzyme was not inhibited by potassium clavulanate or BRL 42715 but
was inhibited byp-chloromercuribenzoate, mercuric chloride, and EDTA. The P-lactamase was unstable in 50
mM sodium phosphate buffer (pH 8.0) but stable in 50 mM Tris HCI (pH 8.0). The other j8-lactamases focused
as a series of different isoelectric points, ranging from pl 5.2 to 6.6. Together, these enzymes exhibited a broad
spectrum of activity, hydrolyzing most classes of j-lactams but not imipenem or aztreonam. Their molecular
size was 48 kDa by Sephadex gel filtration and 24 kDa by SDS-PAGE, indicating that they were enzymes
consisting of two equal subunits. They were inhibited by p-chloromercuribenzoate, mercuric chloride,
potassium clavulanate, and BRL 42715 but not EDTA. This study demonstrated that X. maltophilia produces
more than just the Li and L2 P-lactamases.
Xanthomonas maltophilia is the only member of the genus
Xanthomonas that is pathogenic to humans. This species rests
uneasily within this genus, however, and a recent report has
proposed that it be placed in a new genus, which includes a
single species, Stenotrophomonas maltophilia (24). They are
glucose-nonfermenting, gram-negative bacilli and are increas-
ingly recognized as an important opportunistic pathogen, often
affecting patients with lowered defense mechanisms (12, 21, 22,
29). The species is commonly resistant to a wide range of
,-lactams as well as other classes of antimicrobial agents (11,
15, 22). This resistance has been attributed to the interplay
between outer membrane impermeability (20) and the produc-
tion of two potent ,B-lactamases. Li, a metallo-o-lactamase
(31), and L2, described as an unusual cephalosporinase (30),
hydrolyze virtually the entire spectrum of ,B-lactams. It has
been assumed that all strains produced the Li and L2 enzymes.
However, recent studies have shown an unexpected heteroge-
nicity among 13-lactamases produced by this species (9, 19).
Both studies reported several ,B-lactamases differentiated by
their isoelectric points. In the study by Cullmann and Dick (9),
none of the strains examined produced more than one ,B-lac-
tamase. In this study, we report the biochemical properties of
,-lactamases produced by seven strains of X maltophilia
isolated from blood cultures at the Edinburgh Royal Infirmary
during 1984 to 1991.
(Part of this work was presented at the 33rd Interscience
Conference on Antimicrobial Agents and Chemotherapy [25].)
MATERIALS AND METHODS
Bacterial strains. Seven strains of X maltophilia were
examined. All strains were isolated from blood cultures taken
at the Edinburgh Royal Infirmary during 1984 to 1991. They
were stored as lyophilized cultures until required. All strains
were identified by the API 20NE identification strip.
* Corresponding author.
Antimicrobial agents. The following antibiotics were tested
and obtained from the following companies: penicillin and
ampicillin from Sigma Chemical Co. (Dorset, England), BRL
42715 and potassium clavulanate from SmithKline Beecham
(Welwyn Garden City, England), piperacillin from Lederle
Laboratories (Gosport, England), imipenem from Merck
Sharp & Dohme (Hoddesdon, England), ceftazidime and
cefuroxime from Glaxo Laboratories Ltd. (Uxbridge, En-
gland), cefotaxime and gentamicin from Roussel Laboratories
Ltd. (Uxbridge, England), azlocillin and ciprofloxacin from
Bayer (Newbury, England), and aztreonam from Bristol-Myers
Squibb (Hounslow, England).
Antimicrobial susceptibility tests. MICs were determined by
the agar dilution method. All assays were performed on
Mueller-Hinton agar (Oxoid Ltd., Basingstoke, England). The
inoculum used, approximately 104 CFU/ml, was applied with a
Denley multipoint inoculator (Billinghurst, England). Plates
were incubated overnight at 37°C. Each MIC was determined
as the lowest concentration of antibiotic that inhibited visible
growth.
IEF. Samples were applied to a polyacrylamide gel contain-
ing ampholines with a pH range of 3.5 to 10.6 or a 1:1 mixture
of pH 3.5 to 10.6 and pH 4 to 6 as previously described (18).
Isoelectric focusing (IEF) was carried out at 4°C at 1 W
(constant), 500 V (limiting), and 20 mA (limiting) for 18 h.
Gels were quantified with pl standard markers (BDH Ltd.,
Poole, England) and stained by overlaying the gels with filter
paper soaked in nitrocefin (1 mM) either directly or after a
30-s overlay with various inhibitors (1 mM potassium clavu-
lanate, 1 mM aztreonam, 1 mM cloxacillin, 1 mM EDTA, and
100 puM BRL 42715) soaked in filter paper as previously
described (2).
Assessment of inducibility of 1I-lactamase. Ten-milliliter
volumes of Mueller-Hinton broth were grown overnight at
37°C with continuous shaking. One milliliter of overnight
culture was added to 9 ml of prewarmed Mueller-Hinton broth
and incubated for a further 90 min. Either cefotaxime or
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TABLE 1. Susceptibilities ofX maltophilia isolates to various antibiotics
MIC (pUg/ml)a
Strain Yr isolated
AMP PIP AZL CXM CrX CAZ IMP AZM CIP GEN
5B105 1984 >256 >256 >256 >256 128 >256 256 >256 4 64
6B52 1985 >256 128 16 >256 128 256 128 >256 8 128
6B133 1985 >256 >256 >256 >256 128 >256 >256 >256 8 128
6B295 1985 >256 >256 >256 >256 128 >256 256 >256 4 64
7B78 1986 >256 64 16 >256 64 128 256 256 4 4
12B286 1991 >256 128 32 >256 128 128 64 >256 4 256
12B346 1991 >256 256 256 >256 256 >256 128 >256 2 32
a Abbreviations: AMP, ampicillin; PIP, piperacillin; AZL, azlocillin; CXM, cefuroxime; CTX, cefotaxime; CAZ, ceftazidime; IMP, imipenem; AZM, aztreonam; CIP,
ciprofloxacin; GEN, gentamicin.
imipenem was then added at one-fourth the MIC. Control
flasks with no added inducer were established. After incuba-
tion for a further 2 h, cells were harvested and washed and the
1-lactamase was released by sonication; the procedure was
repeated after 4 h. Enzyme activity was measured by UV
spectrophotometry. Nitrocefin (100 ,uM) was used as the test
substrate. Protein estimation was measured as previously de-
scribed (34).
Large-scale preparation of (3-lactamases. Mueller-Hinton
broths (100 ml) were inoculated with the strain under study
and grown overnight with shaking at 37°C. Cultures were then
added to 900 ml of the same prewarmed broth, and incubation
continued under the same conditions for 90 min. For induc-
tion, imipenem was then added at one-fourth the MIC. Incu-
bation was continued for a further 3 h. After 3 h, bacterial cells
were harvested by centrifugation at 4°C. The pellet was washed
in 50 mM Tris HCl buffer (pH 8.0) and recentrifuged. The
pellet was resuspended in 4 ml of the same buffer and
disrupted by ultrasonication (8 ,um for 1 min, three times)
(MSE Soniprep 150; MSE Instruments, Crawley, United King-
dom) with constant cooling in an ice water bath. The prepa-
ration was partially purified by passing it through a SephadexG-150 column (2 cm by 90 cm) (Pharmacia, Uppsala, Sweden)
previously equilibrated with 50 mM Tris HCl buffer (pH 8.0)
containing 0.1 mM zinc sulfate. Samples were eluted with the
same buffer with a flow rate of 12 ml/h. P-Lactamase activity
was detected with the chromogenic cephalosporin nitrocefin.
The molecular mass on this column was determined as previ-
ously described (1). The molecular weight standards were alco-
hol dehydrogenase (150,000), bovine serum albumin (66,000),
and cytochrome c (12,384).
Purification of ,3-lactamase by electrodialysis. Five hundred
microliters of the partially purified ,-lactamase solution pre-
pared fromX maltophilia 5B105 was applied to a preparative
IEF gel containing pH 3.5 to 10.6 and pH 4 to 6 ampholines
in a 1:1 ratio. After focusing as described above, a 1-cm-wide
strip of filter paper soaked in nitrocefin solution was placed
along either side of the gel from the anode to the cathode
to determine the position of the focused ,-lactamases. The
,-lactamase bands were then excised from the gel and placed
into a dialysis sack with a minimal amount of 50 mM sodium
phosphate buffer (pH 7.0). The dialysis sack was placed in the
cathode reservoir of a Mini Sub Cell (Bio-Rad Laboratories
Ltd., Hemel Hempstead, England) previously filled with 50
mM sodium phosphate buffer (pH 7.0). A charge of 150 V was
applied to the sack for 10 min. The dialysis sack was then
removed, and the polyacrylamide gel discarded (28). The
remaining purified P-lactamase preparation was reapplied to
an IEF as described above.
SDS-free (native) PAGE. Sodium dodecyl sulfate (SDS)-free
(native) polyacrylamide gel electrophoresis (PAGE) was per-
formed on the Phastsystem (Pharmacia). The buffer system
used on the strips was 0.88 M L-alanine-0.25 M Tris (pH 8.8).
Buffer strips were made of 2% agarose IEF. Fractions eluted
from the G-150 column that contained all ,B-lactamase bands
(as determined by IEF) were pooled and concentrated to 5 ml
in a centriprep 10 concentrator (Amicon, Danvers, Mass.).
Four microliters of this solution was applied to a Phastgel
homogenous 12.5 minigel. The separations were run as recom-
mended by the manufacturer. ,3-Lactamase activity was visu-
alized with nitrocefin as described above.
Determination of subunit size. The mass of the ,-lactamase
subunit was also estimated by SDS-PAGE (14). ,-Lactamase
extracts were treated with 5.0% 3-mercaptoethanol and 2.5%
SDS at 100°C for 5 min before electrophoresis on a Phastgel
gradient 10 to 15 minigel according to the manufacturer's
instructions. After electrophoresis, gels were incubated for 4 h
in 50mM Tris HCl buffer (pH 8.0) containing 1% Triton X-100
and 0.1 mM zinc sulfate to obtain a renaturation of enzymatic
activity as described previously (17). After renaturation was
complete, visualization of ,B-lactamase activity was obtained by
staining with nitrocefin as described above. Low-molecular-
weight protein standards (Bio-Rad Laboratories) were run
simultaneously under the same conditions and stained with
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FIG. 1. Kinetics of P-lactamase induction forX maltophilia SB1OS.
P-Lactamase activity is expressed as logl0 nanomoles of nitrocefin
hydrolyzed per minute per milligram of protein.
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FIG. 2. IEF patterns of ,B-lactamases from seven strains of X
maltophilia isolated from blood cultures during 1984 to 1991. Lane 1,
5B105; lane 2, 6B52; lane 3, 6B133; lane 4, 6B295; lane 5, 7B78; lane
6, 12B286; lane 7, 12B346.
Coomassie brilliant blue R250. The molecular weight stan-
dards were transposed over the gel with the renatured ,B-lac-
tamases for the molecular masses to be ascertained.
,B-Lactamase assays. Assays of 1-lactamase activity were
performed at 37°C on a Perkin-Elmer X 2 spectrophotometer
with freshly prepared antibiotic solutions in either 50 mM Tris
HCl buffer (pH 8.0) or 50 mM sodium phosphate buffer (pH
7.0) at the wavelength of maximal absorbance for the 1-lactam
ring of each drug over a 5-min period. The following wave-
lengths were used: 238 nm for penicillin and ampicillin, 236 nm
for carbenicillin, 260 nm for cefuroxime and ceftazidime, 265
nm for cefotaxime, 240 nm for azlocillin, 255 nm for cephalo-
ridine, and 299 nm for imipenem. Maximum rate of hydrolysis
(Vm.) andKm values were derived by linear regression analysis
of Lineweaver-Burk plots of initial velocity data at different
substrate concentrations.
Inhibition studies. A solution of enzyme was preincubated
with inhibitor for 5 min at 37°C in either 50 mM Tris HCl
buffer (pH 8.0) or 50 mM sodium phosphate buffer (pH 7.0).
The remaining enzymatic activity was assayed spectrophoto-
metrically with cephaloridine (100 ,M), imipenem (100 ,uM),
or nitrocefin (100 ,uM) as the test substrate.
RESULTS
Antimicrobial susceptibilities. Table 1 shows the results of
antimicrobial susceptibilities. All seven strains examined were
resistant to almost all of the 3-lactams tested, including
imipenem. Only two strains (6B52 and 7B78) were susceptible
to azlocillin (MIC, 16.0 ,ug/ml). All isolates were also resistant
to gentamicin (breakpoint, 1.0 p,g/ml [4]). Ciprofloxacin was
the most effective agent of all compounds tested, with MICs for
five of the seven strains tested either at or below the recom-
mended breakpoint level (4 ,ug/ml) (4).
Inducibility of P-lactamase production. The kinetics of
,B-lactamase induction for strain 5B105 are shown in Fig. 1.
The test substrate was nitrocefin. When imipenem or cefo-
taxime was added as an inducer, P-lactamase activity increased
sharply after less than 1 h. Imipenem was a more potent
inducer of ,-lactamase than cefotaxime was. No discernible
1-lactamase activity was detected in disrupted cells without the
prior addition of an inducer. This result demonstrated that all
3-lactamase activity was inducible. No enzyme activity was
5.55
S .^ =, ^*Am
.4.
4
_*
4.
5.3
l 2 3 4 5 6
FIG. 3. IEF patterns ofX maltophilia 1-lactamases overlaid with
various inhibitors. Lane 1, control; lanes 2 to 6, overlaid with 100 P,M
BRL 42715, 1 mM aztreonam, 1 mM cloxacillin, 1 mM clavulanate,
and 1 mM EDTA, respectively.
detected in the culture filtrate, indicating that the 1-lactamase
was intracellular.
IEF. ,-Lactamase preparations from all seven strains exhib-
ited identical IEF patterns and revealed the presence of at
least four main bands of 3-lactamase activity (pl 6.8, 6.2, 5.55,
and 5.3) and two minor bands (pI 5.2 and 6.6) (Fig. 2). X
maltophilia 5B105 was selected as representative and examined
in more detail.
Polyacrylamide gels were overlaid with various inhibitors to
further elucidate the nature of these ,-lactamases (Fig. 3). The
,B-lactamase band of pl 6.8 was inhibited by overlaying the gel
with 1.0 mM EDTA prior to staining, whereas all other bands
were unaffected. Conversely, the other ,B-lactamase bands were
completely eliminated by the overlay of BRL 42715 and
partially inhibited by potassium clavulanate. Aztreonam and
cloxacillin overlays appeared to have no significant effect on
any of the 1-lactamase bands.
Gel filtration of crude ,B-lactamase. Spectrophotometric
analysis of the fractions eluted from the Sephadex G-150
column and subsequent IEF (Fig. 4) revealed the presence of
at least two distinct enzymes. The f-lactamase with a pl of 6.8
eluted first from the column and hydrolyzed imipenem as well
as nitrocefin; the other ,B-lactamase bands eluted from the
column at the same rate and hydrolyzed nitrocefin but not
imipenem. The molecular masses of the enzymes were calcu-
1 ->~~~~~~~~~~~19 2
FIG. 4. IEF patterns of P-lactamases from X maltophilia 5B105
eluted from a Sephadex G-150 column. Lanes 1 to 19, 15 jil of every
second fraction eluted from a Sephadex G-150 column (fractions 52 to
88) applied to the gel; lane 20, concentrated 13-lactamase preparation
of X. maltophilia 5B105.
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4VE
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FIG. 6. Native PAGE of P-lactamases fromX maltophilia 5B105.
Four microliters of the ,-lactamase preparation was applied at the
cathode. +VE, anode; -VE, cathode.
2 3 4
FIG. 5. IEF of 1-lactamases fromX maltophilia 5B105 purified by
electrodialysis. Lane 1, original 1-lactamase preparation from 5B105;
lanes 2 to 4, 1-lactamase bands (pI 5.3, 5.55, and 6.2, respectively)
purified by electrodialysis.
lated as 96 and 48 kDa, respectively, by comparing peak
activity with the standard proteins.
In preliminary experiments, the P-lactamase of pI 6.8 was
found to be unstable in 50 mM sodium phosphate buffer (pH
7.0) at 37°C and 80% of the activity was lost after 5 min of
incubation in the buffer. The enzyme was stable in 50 mM Tris
HC1 with an optimum pH of 8.0. Therefore, all assays on the
P-lactamase of pI 6.8 were performed with this buffer. The
other ,-lactamases were stable in phosphate buffer, and assays
of these enzymes were performed with 50 mM sodium phos-
phate buffer (pH 7.0).
Purification of j3-lactamase by electrodialysis. Purification
of the three main ,-lactamase bands (pI 5.3, 5.55, and 6.2) that
were eliminated by BRL 42715 was performed by electrodial-
ysis. Each band was excised from the gel, repurified, applied to
an IEF gel, and reseparated (Fig. 5). Each preparation focused
as a single band at exactly the same pl to which it had originally
migrated, indicating that each 3-lactamase was a discrete
P-lactamase rather than a satellite band.
Native PAGE. Native PAGE of the concentrated ,-lacta-
mase preparation from the Sephadex G-150 gel column re-
vealed the presence of four distinct bands of activity, compat-
ible with the concept of four ,B-lactamases (Fig. 6).
SDS-PAGE. Two-milliliter fractions from the Sephadex
G-150 column which contained either the 1-lactamase of pI 6.8
or the 3-lactamases which were inhibited by BRL 42715 were
pooled and concentrated to 200 ,ul. SDS-PAGE analysis of the
partially purified extracts followed by gel renaturation treat-
ment (Fig. 7) showed in each case the presence of a single band
of ,B-lactamase activity, with an apparent molecular mass of 26
kDa for the enzyme of pI 6.8, while the other 3-lactamase
bands showed the presence of a single protein with an apparent
molecular mass of 24 kDa. Data suggest that the enzyme of pl
6.8 is a tetramer of four subunits which are very similar in
molecular mass. Between them, the other ,-lactamases exhib-
ited a single band of 3-lactamase activity by SDS-PAGE,
indicating dimetric enzymes consisting of two subunits of
similar size.
Hydrolysis of j-lactam antibiotics. Assays of ,B-lactamase
hydrolysis of various ,B-lactams were performed with partially
purified extracts from the G-150 column on the 1-lactamase of
pI 6.8. It was clearly evident at this stage that the ,B-lactamases
of lower pI (<6.8) could not be separated, and they were
subsequently pooled. For convenience, these ,B-lactamases are
hereafter designated XM-A and XM-B, respectively (Table 2).
XM-A was primarily a penicillinase and also readily hydro-
lyzed imipenem. It was much less active against all classes of
cephalosporins, although its affinities (low Km values) for
cephalosporins were higher than those for penicillins and
imipenem. Aztreonam was not hydrolyzed. The XM-B en-
zymes exhibited a broad substrate profile, hydrolyzing an
extensive range of P-lactams but not imipenem, ceftazidime, or
aztreonam. Their affinities were higher for cephalosporins than
for penicillins.
Inhibitors. Table 3 shows the effect of inhibitors on the
activities of enzymes. The treatment of XM-A with EDTA
resulted in the complete inhibition of enzymatic activity. This
inhibition was completely reversed after dialysis against 50mM
Tris HCl (pH 8.0) for 30 min and the addition of 0.1 mM zinc
sulfate to the reaction mixture. Enzymatic activity was partially
inhibited by mercuric chloride and p-chloromercuribenzoate
(PCMB) but not by either potassium clavulanate or BRL
42715 (50% inhibitory doses of >50 and >10 p.M, respective-
kDa
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FIG. 7. SDS-PAGE of the r-lactamases fromX maltophilia 5B105.
Lane 1, molecular mass standards; lane 2, P-lactamase bands of XM-B;
lane 3, P-lactamase band of XM-A.
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TABLE 2. Hydrolysis of ,B-lactam antibiotics by XM-A and XM-B
3-lactamases fromX maltophilia 5B105
XM-A XM-B
Substrate Va Relative Km V a Relative Km
max Vmaxb (mM) max Vmaxb (mM)
Penicillin 14.3 100 0.6 1.2 100 0.108
Ampicillin 5.71 39.9 0.34 2.3 191.6 0.22
Carbenicillin 2.0 13.9 0.67 0.45 37.5 0.55
Azlocillin 5.5 38.4 0.24 1.25 104 0.22
Cephaloridine 0.09 0.6 0.22 1.8 150 0.05
Cefuroxime 0.66 4.6 0.133 0.28 23.3 0.076
Cefotaxime 0.303 2.1 0.05 0.19 15.8 0.08
Ceftazidime 0.03 0.2 0.09 NMHC
Imipenem 3.33 23.3 0.25 NMH
Aztreonam NMH NMH
a Expressed as micromoles of substrate hydrolyzed per minute per milliliter of
enzyme solution.
b Relative to the Vmax of penicillin set at 100%.
c NMH, no measurable hydrolysis.
ly). The XM-B enzymes were not affected by the addition of 0.1
mM EDTA but were inhibited by both 1 mM potassium
clavulanate and 100 puM BRL 42715 (50% inhibitory doses of
0.16 and <0.001, respectively). The enzymatic activity ofXM-B
was completely inhibited by the addition of 0.5 mM PCMB and
0.5 mM mercuric chloride (Table 3).
DISCUSSION
There have been few reports that have characterized the
3-lactamases encoded by X maltophilia in detail; it has been
generally assumed that all isolates produce two ,-lactamases,
Li and L2. Recent work, however, has revealed the heteroge-
nicity of ,B-lactamase production by strains ofX maltophilia.
These enzymes have not been characterized in full but have
been differentiated only by virtue of their isoelectric points (9,
19).
All enzymatic activity observed was inducible. The produc-
tion of two inducible P-lactamases is unusual, although it has
previously been reported for strains of Aeromonas spp. (13),
Bacillus cereus (10), and Yersinia enterocolitica (8). Some
Aeromonas spp. have been reported to produce up to three
different P-lactamases (32).
The multiple bands of 1-lactamase activity observed with the
strains examined in this report were difficult to purify to
homogeneity. Repeated attempts to purify each band of ,B-lac-
tamase activity were unsuccessful despite the utilization of
ion-exchange chromatography with different pH buffers (i.e.,
above and below the pI of the P-lactamase bands). Not only
did the distinct bands of P-lactamase fail to separate but the
resulting enzymatic activity of the eluate was very poor. This
technique was especially detrimental to the activity of the
TABLE 3. Effect of various inhibitors and ions on the activity of
the XM-A and XM-B 1-lactamases
% Inhibition of:
Inhibitor Concn (mM)
XM-Aa XM-Bb
PCMB 0.5 69 100
Mercuric chloride 0.5 70 100
EDTA 0.1 100 0
a Nitrocefin (100 ,M) was used as the test substrate.
b Cephaloridine (100 ,M) was used as the test substrate.
XM-A enzyme. However, the ,-lactamase activity could be
separated by. gel filtration into two fractions, XM-A and
XM-B.
Polyacrylamide gel overlays with various inhibitors demon-
strated that XM-A was inhibited by EDTA but not by BRL
42715 (a powerful inhibitor of serine-active-site P-lactamases
[7]), indicating that this enzyme was distinct from the other
bands of activity. Inhibitor overlays also demonstrated that the
XM-B enzymes were inhibited by both BRL 42715 and potas-
sium clavulanate.
The differences in the pIs of the XM-B bands suggest that
they may have undergone amino acid substitution or addition
away from the active site of the enzyme and may physically
differ in their primary structure. Purification by electrodialysis
and subsequent IEF demonstrated that each preparation fo-
cused as a single band of activity at exactly the same pI to
which it had originally migrated. Its small yield of enzyme
made this technique unsuitable for the purification of enzyme
for further studies. Native PAGE of the concentrated partially
purified ,-lactamase preparation revealed the presence of four
distinct bands of activity. Separated by gel filtration, all the
bands that were inhibited by BRL 42715 were eluted at the
same rate, with an apparent molecular mass of 48 kDa. When
the molecular mass was estimated by SDS-PAGE and subse-
quent renaturation of P-lactamase activity, only one band with
a molecular mass of 24 kDa was observed, suggesting a dimeric
enzyme. It is improbable that an organism would encode three
or more ,-lactamases with identical molecular masses and
subunit conformation unless they were closely related, like the
TEM enzymes, and in parallel with the TEM 3-lactamases, the
differences in pIs arise from a few amino acid substitutions.
These results indicated that the ,B-lactamase activity of XM-B
was the result of at least three distinct enzymes and not of
satellite bands. Unfortunately, the identical molecular masses
of these enzymes and the similarities of their pls made
separation of these enzymes impossible, despite employing
cation- and anion-exchange chromatography.
The XM-A enzyme was very similar in physical and bio-
chemical profile to the Li enzyme. It was unstable in sodium
phosphate buffer. The plasmid-mediated metallo-,-lactamase
from Pseudomonas aeruginosa is also unstable in phosphate
buffer (35). The catalytic activity of the XM-A enzyme was
dependent on Zn2+ for activity. Although the restoration of
activity with other metal ions was not attempted in this study,
results suggest that the enzyme is a metallo-,B-lactamase. Both
enzymes share similar pls (Li, pl 6.9). In parallel with the Li
enzyme, the XM-A enzyme also exists as a tetramer in the
active state (molecular mass, 96 kDa), with a subunit molecular
mass of 26 kDa. The inhibitory profiles of both enzymes are
very similar. Both are insusceptible to potassium clavulanate
but susceptible to mercuric chloride. laconis and Sanders (13)
reported that the Li-producing strain they examined was
inhibited by PCMB (20%), whereas in 1982, Saino et al. (31)
reported no inhibition by this compound. Under our test
conditions, PCMB inhibited the enzymatic activity of the
XM-A enzyme by 69%. The zinc-active sites of metallo-,B-
lactamases are thought to include a conserved cysteine residue
(3); therefore, inhibition by PCMB would be expected. As with
other metallo-,B-lactamases (16), XM-A, although exhibiting
predominantly penicillinase activity, also hydrolyzed a broad
range of ,-lactams including imipenem but not the monobac-
tam aztreonam.
The other enzymes described in this report, XM-B, although
differing particularly in their isoelectric points from that of the
L2 enzyme described by Saino et al. (30) (pl 8.4), shared some
similarities with this enzyme. However, it should be noted that
VOL. 38, 1994
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the results obtained with these combined enzymes should be
treated minimally. We have shown that these enzymes have
distinct physically properties (pls); nevertheless, it has not
been unequivocally shown that all these enzymes react in the
same manner. The inhibitor profile of XM-B was similar to
that reported for the L2 enzyme. All of these enzymes were
inhibited by clavulanate, PCMB, and mercuric chloride. EDTA
had no effect on the enzymatic activity of XM-B, indicating
that XM-B does not require a divalent metal ion for catalytic
activity. The inhibition by BRL 42715 suggests these enzymes
are serine-active-site ,B-lactamases. The molecular mass of
these enzymes was 48 kDa by gel filtration, whereas that of
their subunit form was estimated to be 24 kDa by SDS-PAGE.
The results show they are dimers in the native state, similar to
the L2 enzyme (active-form molecular mass, 56 kDa; subunit
molecular mass, 27 kDa). Together, the XM-B group of
enzymes hydrolyzed a broad spectrum of antibiotics, including
penicillins and cephalosporins, but not imipenem or aztreo-
nam, whereas the L2 enzyme was primarily a cephalosporinase,
with poor hydrolytic activity against penicillins.
Neither XM-A nor the XM-B group of enzymes was shown
to hydrolyze aztreonam, although all the strains examined
exhibited high levels of resistance to this drug. Another
explanation of the high level of resistance to aztreonam may be
the low permeability of the outer membrane ofX maltophilia
to the influx of antibiotics (20).
Although the exact genetic locations of the genes which
encode these P-lactamases have not been precisely deter-
mined, the inducibility of the enzymes would suggest that they
are chromosomally mediated. Indeed, from this study and
others (9, 27), there appears to be a paucity of plasmid-
mediated ,B-lactamases in strains ofX maltophilia.
All ,B-lactamases are produced with a single inducer; this
might imply that the enzymes share a common regulatory gene,
although it is known that imipenem is an effective inducer for
more than one 3-lactamase (33).
We have shown that the XM-A enzyme shares biological and
physiological properties with the Li enzyme and clearly be-
longs in group 3 (metallo-13-lactamases [MET-N]) in the
classification scheme of Bush (6); however, full sequencing is
necessary for an absolute determination. The XM-B group of
enzymes appears to be well placed in the Bush class 2b'
(extended-broad-spectrum ,-lactamases inhibited by clavu-
lanic acid [EBS-Y]) (5); however, without cloning the individ-
ual genes into a suitable host and subsequently sequencing the
enzymes, it is not possible to determine whether these enzymes
have diverse biochemical profiles. The XM-A and XM-B
enzymes may be common among strains of X maltophilia.
Cullmann and Dick (9) reported the presence of six distinct
,-lactamases in 19 strains ofX maltophilia. On close scrutiny
of the IEF polyacrylamide gel, there appear to be ,B-lactamases
from strain 858 that are similar to those described in this
report, although Cullmann and Dick do not describe these
enzymes in their text. Recently, Payne et al. (27) reported the
presence of enzymes with similar pIs in two strains of X
maltophilia. It appears that within the speciesX maltophilia, a
number of different ,B-lactamases which differ from the 13-lac-
tamases of most other genera are produced.
Livermore (16) has classified carbapenemases as efficient or
inefficient, depending on whether they confer high or low levels
of carbapenem resistance on the host organism. High levels of
carbapenem resistance have been found only in those organ-
isms that are known to commonly produce a chromosomal
metallo-,B-lactamase. The metallo-p-lactamase of X. malto-
philia is an example. There is also a frightening possibility that
the chromosomal genes that encode the 1-lactamases of this
species may be transposed onto conjugative plasmids. There
have been recent reports of inefficient carbapenemases, al-
though not transferable, from Acinetobacter baumannii (26),
Enterobacter cloacae (23), and Serratia marcescens (36), which
are not of the normal ,B-lactamase complement for the host
species. The increased use of ,B-lactam drugs, particularly the
newer carbapenem compounds, may facilitate the emergence
of this organism as an important pathogen. If the genes
encoding these enzymes acquire the capability to disseminate
among the more common pathogens, it will further diminish
the range of antibiotics available for use in cases of serious
sepsis.
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